+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Hyaluronate Intra-Articular Injection Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sodium Hyaluronate Intra-Articular Injection Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Sodium Hyaluronate Intra-Articular Injection Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082075
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Sodium hyaluronate intra-articular injections have emerged as a vital option in the management of osteoarthritis and other joint-related disorders, offering both symptomatic relief and potential improvements in joint function. These injections, which utilize high-viscosity formulations of the naturally occurring polysaccharide hyaluronic acid, aim to restore synovial fluid viscosity, reduce friction within the joint, and alleviate pain. With an aging global population and rising incidence of musculoskeletal conditions, demand for minimally invasive therapeutic options continues to grow. In parallel, advancements in formulation technologies-ranging from preservative-free multi-dose vials to pre-filled single-dose syringes-are enhancing convenience for clinicians and improving patient compliance.

In recent years, the market has witnessed intensified research into molecular weight variations, optimizing both high- and low-molecular weight hyaluronate for targeted efficacy. Regulatory approvals across major markets, alongside updated clinical guidelines, have propelled adoption in knee, hip, and shoulder osteoarthritis. Technological innovations in delivery devices and cross-linked formulations promise extended residence within the joint space, potentially reducing injection frequency. As we explore the current landscape, this report identifies key trends, emerging challenges, and strategic imperatives shaping the sodium hyaluronate intra-articular injection market.

Key Drivers Shaping the Future of Hyaluronate Injections

The sodium hyaluronate landscape is undergoing transformative shifts driven by clinical innovation, patient-centric delivery systems, and evolving reimbursement frameworks. First, molecular engineering has enabled the development of formulations with tailored viscosities; high-molecular weight polymers aim to mimic healthy synovial fluid, while low-molecular weight variants offer improved tissue penetration and anti-inflammatory properties. Second, delivery innovation is accelerating: pre-filled single-dose syringes reduce preparation time and contamination risk, whereas preservative-free multi-dose vials cater to high-volume clinics seeking cost efficiencies.

Third, payer dynamics and value-based care models are reshaping market access, with an increasing emphasis on real-world evidence and health-economic outcomes. Providers are demanding robust clinical data that demonstrates not only symptomatic relief but also long-term functional improvement and reduced overall healthcare costs. Furthermore, digital health tools-such as remote monitoring of joint function and telemedicine consults-are enhancing patient engagement and streamlining post-injection follow-up. These converging forces are redefining competitive boundaries and setting new benchmarks for product differentiation.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

The introduction of enhanced tariff structures by the United States in 2025 has created a ripple effect across the sodium hyaluronate injection supply chain. Import duties on raw materials and finished injection systems have increased production costs for manufacturers reliant on multinational supply networks. In response, some producers have shifted sourcing to domestic suppliers or alternative geographies, which mitigates exposure but may compromise on scale or cost competitiveness.

Consequently, pricing pressures have intensified for end-users, with clinics and hospitals seeking volume discounts or alternate reagents to preserve margins. Regulatory bodies and industry associations are advocating for streamlined customs procedures and tariff exemptions for critical medical inputs, highlighting the essential nature of hyaluronic acid in maintaining quality of life for osteoarthritis patients. Ultimately, these cumulative tariff impacts underscore the need for supply chain resilience, diversified manufacturing footprints, and proactive engagement with policy stakeholders to safeguard patient access.

In-Depth Segmentation Analysis Reveals Diverse Market Dynamics

An in-depth look at segmentation reveals a multifaceted market defined by product modalities, clinical indications, patient demographics, care settings, injection protocols, manufacturing approaches, molecular composition, distribution strategies, and packaging formats. Based on product type, the market divides into multi-dose vials and single-dose syringes, with multi-dose vials further categorized into preservative-free and with preservatives while single-dose syringes encompass fill-your-own and pre-filled options. Considering application, the landscape covers hip osteoarthritis, knee osteoarthritis, and shoulder osteoarthritis, with knee indications further differentiated into moderate and severe cases. Turning to patient type, adult patients split into elderly and middle-aged cohorts, and pediatric patients into juvenile arthritis and other orthopedic conditions. From the vantage of end users, settings range from clinics and specialty centers-such as orthopedic and pain management clinics-to hospitals, including private and public institutions.

Injection type segmentation distinguishes intra-articular series versus single injections and viscosupplementation products like Monovisc and Orthovisc. When examining manufacturing processes, a dichotomy emerges between biotechnological methods-principally fermentation-based-and chemical synthesis routes. Component composition further segments high-molecular weight versus low-molecular weight hyaluronate, each offering distinct rheological and biological profiles. Distribution channels span institutional sales, via direct tenders and group purchasing organizations, and retail sales through drug stores and online pharmacies. Finally, packaging formats oscillate between traditional glass syringes and modern plastic ampules, reflecting trade-offs in cost, sterility, and environmental considerations.

Regional Market Insights: Geographic Trends and Opportunities

Geographic insights highlight distinct growth patterns and strategic considerations across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, widespread reimbursement schemes and high healthcare expenditure underpin robust uptake, particularly in the United States and Canada, where advanced delivery formats and cross-linked formulations are gaining traction. Meanwhile, in Europe, Middle East & Africa, heterogeneous regulatory environments and variable payer policies necessitate tailored market entry strategies; Western Europe leads in innovative protocol adoption, whereas emerging markets in the Middle East and Africa are fuelled by investment in orthopedic infrastructure.

The Asia-Pacific region presents dynamic opportunities, driven by expanding healthcare access in China and India, growing geriatric populations, and rising awareness of minimally invasive therapies. Localization of manufacturing and partnerships with regional distributors are critical to overcoming tariff barriers and ensuring product availability. Across all regions, collaboration with key opinion leaders and alignment with national osteoarthritis management guidelines remain central to driving clinician endorsement and securing formulary listings.

Leading Players and Strategic Footprints in the Sodium Hyaluronate Space

The competitive landscape features a mix of specialized biotech innovators and diversified pharmaceutical giants. Anika Therapeutics, Inc. leads with proprietary high-molecular weight formulations, while Bausch Health Companies Inc. leverages broad distribution networks for its viscosupplement portfolios. Bioventus LLC has differentiated through evidence-based outcomes and digital support platforms, and Ferring Pharmaceuticals capitalizes on its rheumatology pipeline to integrate hyaluronate offerings.

Fidia Farmaceutici S.p.A. and HyaloEos SRL focus on regional excellence in Europe, employing fermentation-based production to optimize purity. Horizon Therapeutics plc and Pfizer Inc. invest heavily in clinical trials to expand indications beyond osteoarthritis, targeting post-operative joint rehabilitation. LG Chem Ltd. and Teijin Limited advance manufacturing efficiency through chemical synthesis innovations. Sanofi S.A. applies its global commercial infrastructure to penetrate emerging markets, while Seikagaku Corporation emphasizes proprietary cross-linking technologies. Zimmer Biomet Holdings, Inc. integrates hyaluronate products within its orthopedic device portfolio, offering comprehensive joint care solutions.

Actionable Strategies for Industry Leaders to Stay Ahead

Industry leaders should pursue a multifaceted strategy to capture growth and build resilience. First, diversifying supply chains by establishing regional manufacturing hubs will mitigate tariff exposure and ensure continuity of supply. Second, investing in high-value formulation enhancements-such as cross-linked matrices or combination therapies with anti-inflammatories-will deepen clinical differentiation and justify premium pricing.

Third, forging strategic partnerships with digital health platforms can enrich post-injection monitoring and support value-based care models, strengthening reimbursement negotiations. Fourth, prioritizing real-world evidence generation through registries and observational studies will demonstrate long-term cost-effectiveness and patient-centric outcomes. Fifth, tailoring market access approaches to regional regulatory and payer nuances-leveraging direct tenders, group purchasing organizations, or bundled care agreements-will maximize uptake across diverse healthcare ecosystems. By executing these tactics in concert, organizations can secure competitive advantage and drive sustained expansion.

Conclusion: Navigating a Dynamic Hyaluronate Injection Landscape

In conclusion, the sodium hyaluronate intra-articular injection market stands at a pivotal juncture, characterized by rapid innovation, evolving regulatory landscapes, and shifting global trade dynamics. Manufacturers and stakeholders who embrace advanced formulation technologies, fortify supply chain robustness, and generate compelling real-world evidence will be best positioned to meet the complex needs of patients and payers. Regional nuances demand locally tailored strategies, while strategic collaborations-both commercial and clinical-will amplify market penetration and patient access.

As the sector continues to evolve, embracing a holistic approach that integrates product development, digital health, and policy advocacy will be key to driving long-term value. The insights presented here serve as a roadmap for organizations seeking to navigate uncertainty, capitalize on emerging opportunities, and ultimately improve outcomes for individuals living with osteoarthritis and other joint disorders.

Market Segmentation & Coverage

This research report categorizes the Sodium Hyaluronate Intra-Articular Injection Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Multi-Dose Vial
    • Preservative-Free
    • With Preservatives
  • Single-Dose Syringe
    • Fill-Your-Own
    • Pre-filled
  • Hip Osteoarthritis
  • Knee Osteoarthritis
    • Moderate Knee OA
    • Severe Knee OA
  • Shoulder Osteoarthritis
  • Adult Patients
    • Elderly
    • Middle-Aged
  • Pediatric Patients
    • Juvenile Arthritis
    • Orthopedic Conditions
  • Clinics and Specialty Centers
    • Orthopedic Clinics
    • Pain Management Clinics
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Intra-Articular Injections
    • Series Injections
    • Single Injections
  • Viscosupplementation
    • Monovisc
    • Orthovisc
  • Biotechnological Process
    • Fermentation-Based
  • Chemical Synthesis Process
  • High-Molecular Weight Hyaluronate
  • Low-Molecular Weight Hyaluronate
  • Institutional Sales
    • Direct Tender
    • Group Purchasing Organizations
  • Retail Sales
    • Drug Stores
    • Online Pharmacies
  • Glass Syringes
  • Plastic Ampules

This research report categorizes the Sodium Hyaluronate Intra-Articular Injection Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Sodium Hyaluronate Intra-Articular Injection Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Anika Therapeutics, Inc.
  • Bausch Health Companies Inc.
  • Bioventus LLC
  • Ferring Pharmaceuticals
  • Fidia Farmaceutici S.p.A.
  • Horizon Therapeutics plc
  • HyaloEos SRL
  • LG Chem Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Teijin Limited
  • Zimmer Biomet Holdings, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sodium Hyaluronate Intra-Articular Injection Market, by Product Type
8.1. Introduction
8.2. Multi-Dose Vial
8.2.1. Preservative-Free
8.2.2. With Preservatives
8.3. Single-Dose Syringe
8.3.1. Fill-Your-Own
8.3.2. Pre-filled
9. Sodium Hyaluronate Intra-Articular Injection Market, by Application
9.1. Introduction
9.2. Hip Osteoarthritis
9.3. Knee Osteoarthritis
9.3.1. Moderate Knee OA
9.3.2. Severe Knee OA
9.4. Shoulder Osteoarthritis
10. Sodium Hyaluronate Intra-Articular Injection Market, by Patient Type
10.1. Introduction
10.2. Adult Patients
10.2.1. Elderly
10.2.2. Middle-Aged
10.3. Pediatric Patients
10.3.1. Juvenile Arthritis
10.3.2. Orthopedic Conditions
11. Sodium Hyaluronate Intra-Articular Injection Market, by End-User
11.1. Introduction
11.2. Clinics and Specialty Centers
11.2.1. Orthopedic Clinics
11.2.2. Pain Management Clinics
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
12. Sodium Hyaluronate Intra-Articular Injection Market, by Injection Type
12.1. Introduction
12.2. Intra-Articular Injections
12.2.1. Series Injections
12.2.2. Single Injections
12.3. Viscosupplementation
12.3.1. Monovisc
12.3.2. Orthovisc
13. Sodium Hyaluronate Intra-Articular Injection Market, by Manufacturing Process
13.1. Introduction
13.2. Biotechnological Process
13.2.1. Fermentation-Based
13.3. Chemical Synthesis Process
14. Sodium Hyaluronate Intra-Articular Injection Market, by Component Composition
14.1. Introduction
14.2. High-Molecular Weight Hyaluronate
14.3. Low-Molecular Weight Hyaluronate
15. Sodium Hyaluronate Intra-Articular Injection Market, by Distribution Channel
15.1. Introduction
15.2. Institutional Sales
15.2.1. Direct Tender
15.2.2. Group Purchasing Organizations
15.3. Retail Sales
15.3.1. Drug Stores
15.3.2. Online Pharmacies
16. Sodium Hyaluronate Intra-Articular Injection Market, by Packaging
16.1. Introduction
16.2. Glass Syringes
16.3. Plastic Ampules
17. Americas Sodium Hyaluronate Intra-Articular Injection Market
17.1. Introduction
17.2. Argentina
17.3. Brazil
17.4. Canada
17.5. Mexico
17.6. United States
18. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market
18.1. Introduction
18.2. Australia
18.3. China
18.4. India
18.5. Indonesia
18.6. Japan
18.7. Malaysia
18.8. Philippines
18.9. Singapore
18.10. South Korea
18.11. Taiwan
18.12. Thailand
18.13. Vietnam
19. Europe, Middle East & Africa Sodium Hyaluronate Intra-Articular Injection Market
19.1. Introduction
19.2. Denmark
19.3. Egypt
19.4. Finland
19.5. France
19.6. Germany
19.7. Israel
19.8. Italy
19.9. Netherlands
19.10. Nigeria
19.11. Norway
19.12. Poland
19.13. Qatar
19.14. Russia
19.15. Saudi Arabia
19.16. South Africa
19.17. Spain
19.18. Sweden
19.19. Switzerland
19.20. Turkey
19.21. United Arab Emirates
19.22. United Kingdom
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Anika Therapeutics, Inc.
20.3.2. Bausch Health Companies Inc.
20.3.3. Bioventus LLC
20.3.4. Ferring Pharmaceuticals
20.3.5. Fidia Farmaceutici S.p.A.
20.3.6. Horizon Therapeutics plc
20.3.7. HyaloEos SRL
20.3.8. LG Chem Ltd.
20.3.9. Pfizer Inc.
20.3.10. Sanofi S.A.
20.3.11. Seikagaku Corporation
20.3.12. Teijin Limited
20.3.13. Zimmer Biomet Holdings, Inc.
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET MULTI-CURRENCY
FIGURE 2. SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET MULTI-LANGUAGE
FIGURE 3. SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 22. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 24. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 28. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 34. SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRESERVATIVE-FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY WITH PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY FILL-YOUR-OWN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRE-FILLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MODERATE KNEE OA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SEVERE KNEE OA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MIDDLE-AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY JUVENILE ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ORTHOPEDIC CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SERIES INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MONOVISC, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ORTHOVISC, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY FERMENTATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CHEMICAL SYNTHESIS PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HIGH-MOLECULAR WEIGHT HYALURONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY LOW-MOLECULAR WEIGHT HYALURONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY GLASS SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PLASTIC AMPULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 133. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 135. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 136. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 138. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 140. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 141. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 143. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 145. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 146. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 147. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 148. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 149. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 150. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 152. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 153. CANADA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 154. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 156. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 166. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 168. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 169. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 171. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 173. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 174. MEXICO SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 240. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 242. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 243. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2030 (USD MILLION)
TABLE 245. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 247. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 248. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY CLINICS AND SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 250. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 252. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INTRA-ARTICULAR INJECTIONS, 2018-2030 (USD MILLION)
TABLE 253. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 254. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 255. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY BIOTECHNOLOGICAL PROCESS, 2018-2030 (USD MILLION)
TABLE 256. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY COMPONENT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 257. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY INSTITUTIONAL SALES, 2018-2030 (USD MILLION)
TABLE 259. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY RETAIL SALES, 2018-2030 (USD MILLION)
TABLE 260. CHINA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 261. INDIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. INDIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY MULTI-DOSE VIAL, 2018-2030 (USD MILLION)
TABLE 263. INDIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY SINGLE-DOSE SYRINGE, 2018-2030 (USD MILLION)
TABLE 264. INDIA SODIUM HYALURONATE INTRA-ARTICULAR INJECTION MARKET SIZE, BY APPLICATION, 20

Companies Mentioned

  • Anika Therapeutics, Inc.
  • Bausch Health Companies Inc.
  • Bioventus LLC
  • Ferring Pharmaceuticals
  • Fidia Farmaceutici S.p.A.
  • Horizon Therapeutics plc
  • HyaloEos SRL
  • LG Chem Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Teijin Limited
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Sodium Hyaluronate-based Products - Global Strategic Business Report - Product Image

Sodium Hyaluronate-based Products - Global Strategic Business Report

  • Report
  • 73 Pages
  • Global
From
Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Sodium Hyaluronate Market: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Sodium Hyaluronate Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 380 Pages
  • Global
From
Sodium Hyaluronate (HA) (CAS 9067-32-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Sodium Hyaluronate (HA) (CAS 9067-32-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 85 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.